February 08, 2011 at 09:19 AM EST
XIDE is poised to pop after topping 3Q profit expectations
Today's column includes the latest quarterly results from Exide Technologies (XIDE), a new "sell" rating for Amylin Pharmaceuticals, Inc...( Read More )
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here